Works matching IS 10538569 AND DT 2022 AND VI 31 AND IP 9
Results: 14
Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 992, doi. 10.1002/pds.5489
- By:
- Publication type:
- Article
Development and performance characteristics of novel code‐based algorithms to identify invasive Escherichia coli disease.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 983, doi. 10.1002/pds.5505
- By:
- Publication type:
- Article
Positive predictive values of hematological procedure codes in the Danish National Patient Registry—A population‐based validation study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 963, doi. 10.1002/pds.5485
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 1, doi. 10.1002/pds.5498
- Publication type:
- Article
Parity in female authorship in Australian pharmacoepidemiology research leveraging medicine dispensing data: How well are we doing?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 1010, doi. 10.1002/pds.5450
- By:
- Publication type:
- Article
Bayesian symmetry analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 1007, doi. 10.1002/pds.5449
- Publication type:
- Article
Using structural topic modelling to reveal patterns in reports on opioid drugs in a pharmacovigilance database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 1003, doi. 10.1002/pds.5502
- By:
- Publication type:
- Article
Machine learning for improving high‐dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 932, doi. 10.1002/pds.5500
- By:
- Publication type:
- Article
Validity of claims data for identifying cancer incidence in the Japan public health center‐based prospective study for the next generation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 972, doi. 10.1002/pds.5494
- By:
- Publication type:
- Article
Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databases.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 953, doi. 10.1002/pds.5492
- By:
- Publication type:
- Article
Systematically exploring repurposing effects of antihypertensives.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 944, doi. 10.1002/pds.5491
- By:
- Publication type:
- Article
Validation of actinic keratosis diagnosis and treatment codes among veterans living with HIV.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 998, doi. 10.1002/pds.5430
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 1013, doi. 10.1002/pds.5284
- Publication type:
- Article
Profiling real‐world data sources for pharmacoepidemiologic research: A call for papers.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 9, p. 929, doi. 10.1002/pds.5481
- By:
- Publication type:
- Article